Glenmede Trust’s CapForce IBD 50 ETF FFTY Stock Holding History

Glenmede Trust’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,500	Closed	-$52K	–	2499
2020 Q1	$52K	Hold	1,500	–	–	﹤0.01%	1674
2019 Q4	$52K	Buy	+1,500	New	+$50.7K	﹤0.01%	1674
2019 Q3	–	Sell	-1,772	Closed	-$60	–	3051
2019 Q2	$60	Hold	1,772	–	–	﹤0.01%	1588
2019 Q1	$59	Buy	+1,772	New	+$55.8K	﹤0.01%	1608

Other funds holding FFTY

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Glenmede Trust's FFTY Position: Q2 2020 in Review

Glenmede Trust sold out of CapForce IBD 50 ETF (FFTY) in Q2 2020, closing a stake of 1,500 shares — an estimated $52K sold.

Glenmede Trust first reported a position in FFTY in Q1 2019 and held it in 4 quarters. The position peaked at $52K in Q1 2020. 71 funds tracked by Wall St. Rank hold FFTY as of Q2 2020.

Glenmede Trust reported no remaining CapForce IBD 50 ETF position as of Q2 2020 after selling out during the quarter.
Glenmede Trust sold 1,500 CapForce IBD 50 ETF shares in Q2 2020, an estimated $52K.
Glenmede Trust first reported a position in CapForce IBD 50 ETF in Q1 2019 and held it in 4 quarters.
Glenmede Trust's CapForce IBD 50 ETF position peaked at $52K in Q1 2020.
71 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.